# FDA Inspection 1314136 - Versiti Indiana, Inc. - April 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/44c2e11e-d3e2-483f-ba3c-807679ce08c5
Source feed: FDA_Inspections

> FDA Inspection 1314136 for Versiti Indiana, Inc. on April 23, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314136
- Company Name: Versiti Indiana, Inc.
- Inspection Date: 2026-04-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1182009 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/62992320-3f51-431c-b09a-25eb3c31675f)
- [FDA Inspection 1182009 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/e5457b5d-1684-4632-8025-1a427b0da506)

Company: https://www.keypedia.com/companies/versiti-indiana-inc/f73a9aa7-fe30-458c-ae6a-174c48b2febb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d